Enabling trade in frontier markets.
Nazryx works with dozens of manufacturers and distributors to streamline sourcing, registration and market entry across 7 markets in Africa and Asia.
You buy and sell medicines.
We run the sourcing and market-intelligence function behind it — finding what your categories are short of, naming the manufacturer, settling the registration route and reporting on your market every week. Not a database you log into. A function you stop having to staff.
See what we run →You make medicines.
We place them into markets that already need them — distribution partners found and proven from the register, your portfolio ranked market by market, registration carried through to submission, and the sales work after it.
See how we place product →A data-based approach to export success.
We study demand patterns, competitive positioning and regulatory trends across each target geography, and use that intelligence to ensure every product has trackable metrics for manufacturers and distributors alike to see.
- Direct market forecasts
- Local pricing dynamics
- Vetted distributor surveys
- Regulatory framework
- CTD dossier assessment
- Quarterly growth reviews
Final score for this product for Tanzania.
View marketing guide for product to launch into the Tanzanian market.
Product has high price sensitivity and relatively low margins.
Significant demand across the Tanzanian market for product.
Minimal competition: 3 registrations and 1 under review.
Product has a significantly higher average registration time.
A catalogue built by class, not by brochure.
We build our portfolio from analytical data drawn from hundreds of sources, used to verify demand, feasibility, market fit and other factors before we even begin pitching our SKUs to potential distributors.
Across target countries including Kenya, Iraq, Cambodia, Uganda, Rwanda and other frontier emerging markets.
From Pakistani manufacturers across hundreds of SKUs in several verticals.
We go through data at speed to give every SKU accurate demand predictions, best pricing zones and dozens of other benchmarks that make exports an opportunity, not a burden.
Why not in-house?
We maintain access to data and systems built from the ground up solely to deliver insight into pharmaceutical and medical SKUs, so decisionmakers are informed, up to date and ready to deliver.
Nazryx exists to complement existing sales teams rather than replace them — so teams spend more time on sales and less time finding leads or conducting market surveys.
A supplier list tells you who exists. It doesn't tell you what's open.
Most sourcing and export decisions get made from catalogues, brochures and whoever answered the email — because those are the things that are easy to get hold of. What actually decides whether a product will sell sits in the national registers, and it only gives anything up when the whole thing is read rather than searched.
A widely used molecule came back as saturated — on paper, a category nobody should enter. Every registration was for animal use. There was no human-medicine supplier in the country at all, against a serious disease burden.
An entire clinical category with nothing registered against it in a market of sixty million people — and a distributor there who had asked us for one of those twelve by name, weeks before we found the rest.
Manufacturers and product portfolios are added continuously as new markets open.
Let's work together
Garden Town, Lahore
Slough, London
Bostandikskyi, Almaty